With A Potential Blockbuster Alzheimer’s Drug, Is This Ten-Bagger Stock Still A Buy?
With a potential blockbuster drug in its pipeline that would also be the first new therapy for Alzheimer’s disease in decades, the stock featured in…
Bearish Market
Options For An Uncertain Earnings Season
With second-quarter earnings season getting underway against what the author of today’s article acknowledges is “one of the most uncertain backdrops ever”, he advises that…
Establish A Strategic Risk Range – And Avoid “Getting Whipsawed By The Market”
“It’s important to not overreact to short-term market noise,” advises the author of today’s article. The problem, of course, is that overreacting to short-term market…